Page last updated: 2024-11-03

1,6-bis(cyclohexyloximinocarbonyl)hexane and Breast Cancer

1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Breast Cancer in 1 studies

1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nieman, MT1
Prudoff, RS1
Johnson, KR1
Wheelock, MJ1

Other Studies

1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Breast Cancer

ArticleYear
N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.
    The Journal of cell biology, 1999, Nov-01, Volume: 147, Issue:3

    Topics: beta Catenin; Blotting, Western; Breast Neoplasms; Cadherins; Cell Movement; Cell Size; Coculture Te

1999